O’Ryan.Health, a leader in at-home pediatric healthcare innovation, today announced it has become the first US company to launch two, parent-led observational studies “The Healthy Kids Study” and “The JDM Study,” involving the in-home collection of pediatric blood from children. Juvenile Dermatomyositis (JDM) is an ultra-rare pediatric autoimmune disorder. These studies, made possible through a partnership with YourBio Health, a pioneer in capillary blood sampling, allow parents to safely and efficiently sample their children’s blood without having to travel to a medical facility.
Alzheimer’s disease is the most common cause of dementia, responsible for up to 80% of dementia cases worldwide.
In a mouse model, KCL-286, a drug that has passed phase 1 trials for spinal injuries in people, repaired DNA breaks and…
Neko Health has raised US$700m to fund its first US expansion, new clinics and further development of its preventative health tech.
The Series C round follows a US$260m Series B in January 2025.
Founded by Spotify’s Daniel Ek and Hjalmar…